Patient Education Sheet Library
Search Results
Etoposide, Doxorubicin, Cisplatin, and Mitotane
The combination of etoposide, doxorubicin, cisplatin, and mitotane (EDP-M) is used for cancer of the…
Treatment Given by Infusion Treatment Taken by MouthDownloads:
Download (English)Mycophenolate
Mycophenolate is used for graft-versus-host disease (GVHD).
Treatment Given by Infusion Treatment Taken by MouthDownloads:
Letermovir
Letermovir is used for the prevention of cytomegalovirus (CMV) infection.
Treatment Given by Infusion Treatment Taken by MouthDownloads:
Chlorambucil Taken by Mouth
Chlorambucil is used for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), malignant lymphomas…
Treatment Taken by MouthDownloads:
Chlorambucil and Obinutuzumab
The combination of chlorambucil and obinutuzumab is used for chronic lymphocytic leukemia (CLL) or small…
Treatment Given by Infusion Treatment Taken by MouthDownloads:
Belzutifan and Pembrolizumab
The combination of belzutifan and pembrolizumab is used for a type of kidney cancer called…
Treatment Given by Infusion Treatment Taken by MouthDownloads:
Anagrelide
Anagrelide is used for thrombocythemia. People with thrombocythemia have a higher-than-normal number of platelets.
Treatment Taken by MouthDownloads:
Decitabine/Cedazuridine and Venetoclax
The combination of decitabine/cedazuridine and venetoclax is used for acute myeloid leukemia (AML).
Treatment Taken by MouthDownloads:
Acalabrutinib, Venetoclax, and Obinutuzumab
The combination of acalabrutinib, venetoclax, and obinutuzumab is used for chronic lymphocytic leukemia (CLL) or…
Treatment Given by Infusion Treatment Taken by MouthDownloads:
Acalabrutinib and Venetoclax
The combination of acalabrutinib and venetoclax is used for chronic lymphocytic leukemia (CLL) or small…
Treatment Taken by MouthDownloads:
Popular Searches
PES Review Committee
The Patient Education Sheet (PES) Committee is a multidisciplinary team of oncology professionals who guide the development and review of these important resources. This committee ensures that every PES is accurate, clear, and meaningful for patients and caregivers navigating cancer treatment.
Led by NCODA and supported through collaboration with three leading professional organizations—ACCC, HOPA, and ONS—the committee combines expertise from across the oncology care spectrum. Together, they uphold best practices, promote consistency in patient education, and remain committed to improving outcomes through accessible, patient-centered information.
